[View original text]
Monopolized cervical cancer business in China through joint development with Canada’s D-Wave Systems, a quantum computer developer
As people's demand and expectations for medical care and health care are increasing day by day and the paradigm of healthcare is also shifting from post-treatment to preventive and health care, grafting the medical field and information and communication technology (ICT) has become essential. In particular, the detection and treatment of cervical cancer, which
is a threat to women, is of great significance.
More accurate and high-quality ICT data is needed because the cure rate is significantly lowered and female function can be lost when detected in the middle stage. Buzzpole Co., Ltd. (CEO Jae-hoon Jeong) is a smart human care company that has been steadily researching medical ICT since its launch in 2014. It realized the advancement of cancer diagnosis
engine in earnest by developing ‘Cerviclinic AI’, an AI-based remote diagnosis system for cervical cancer.
Currently, Buzzpole monopolizes the cervical cancer business in China through joint development with D-Wave Systems, a Canadian developer of quantum computers. D-Wave Systems is the world's No. 1 company in name and reality, supplying quantum computers to Google and NASA. In addition, Buzzpole is also in the process of collaborating with a famous
university hospital in Korea. By actively utilizing high-quality Korean medical technology and developing a lesion classification engine, it already has the highest level of image data
and medical examination data, so the scale already can be commercialized immediately.
On 29th of March, As announced by the National IT Industry Promotion Agency, leading universities and global ICT companies such as Google are releasing AI technology-related
source codes free of charge, and domestic hospitals are also launching their own AI image reading solutions. In line with this, Buzzpole operates its own research institute and has
business agreements with famous domestic and foreign hospitals and specialists. ProfessorJae-yun Song of the Department of Obstetrics and Gynecology at Korea University Anam
Hospital said, “By applying Serbiclinic AI to early diagnosis of cervical cancer, we are increasing the concordance rate between artificial intelligence diagnosis results and final biopsy results, and we are also actively participating in a project that provides clinical consultation for patients in China and Southeast Asia in Korea.”
The Thai government is also showing interest in the structure in which synergy is maximized by adding the technology of Buzzpole and medical specialists working in the industry, and plans to expand its business to the world starting with China in May at the earliest.
2019-04-10 03:00 / Donga.com / Reporter Hyun-ji Tae
Comments can be added by Member only